Published in

Elsevier, The Lancet Diabetes and Endocrinology, 1(12), p. 39-50, 2024

DOI: 10.1016/s2213-8587(23)00321-2

Links

Tools

Export citation

Search in Google Scholar

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Journal article published in 2024 by N. Staplin, R. Haynes, Pk Judge, C. Wanner, Jb Green, J. Emberson, D. Preiss, Kj Mayne, Sya Ng, E. Sammons, D. Zhu, M. Hill, W. Stevens, K. Wallendszus, S. Brenner and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO